Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

INMINM
13 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in INMED PHARMACEUTICALS INC

CITADEL ADVISORS LLC holds 46,973 shares of INM (INMED PHARMACEUTICALS INC), worth $30,293 as of 2026-Q1. This is a new position.

Current Value

$30,293

Current Shares

46,973

Total Value Change

-$26,707

Total Shares Change

+29,762

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
46,973
-
$30,2930.0%$0.76
30
2024-Q4
Exited
0
-100.0%
$00.0%$4.59
0
2024-Q3
Increased
56,666
+368.4%
$13,2660.0%$4.64
19
2024-Q2
Decreased
12,097
-4.9%
$3,2120.0%$5.32
0
2024-Q1
Decreased
12,725
-62.6%
$4,4790.0%$7.28
0
2023-Q4
New
34,009
-
$14,1480.0%$8.32
27
2022-Q3
Exited
0
-100.0%
$00.0%$114.80
0
2022-Q2
New
12,966
-
$6,0000.0%$245.00
24
2022-Q1
Exited
0
-100.0%
$00.0%$430.00
0
2021-Q4
Decreased
11,060
-38.4%
$14,0000.0%$670.00
0
2021-Q3
Increased
17,942
+17.2%
$31,0000.0%$910.00
16
2021-Q2
Decreased
15,310
-11.1%
$49,0000.0%$1,620.00
0
2021-Q1
New
17,211
-
$57,0000.0%$1,565.00
32

Other major holders of INM: Hudson Bay Capital Management LP, TWO SIGMA ADVISERS, LP, TWO SIGMA INVESTMENTS, LP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used